Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit (Tables)

v3.20.4
Stockholders' Deficit (Tables)
6 Months Ended
Dec. 31, 2020
Equity [Abstract]  
Schedule of Stock Warrant Activity

Warrant detail for the six months ended December 31, 2020 is reflected below:

 

    Number of Warrants     Weighted Average Exercise Price Per Warrant     Remaining Contract Term (# years)  
Warrants outstanding and exercisable at June 30, 2020     83,205     $ 4.00       2.01  
Warrants issued     185,955     $ 4.80       5.00  
Warrants forfeited     -     $ -       -  
Warrants outstanding at December 31, 2020     269,160     $ 4.55       3.66  
Warrants exercisable at December 31, 2020     83,205     $ 4.00       1.50  

 

Warrant detail for the six months ended December 31, 2019 is reflected below:

 

    Number of Warrants     Weighted Average Exercise Price Per Warrant     Remaining Contract Term (# years)  
Warrants outstanding and exercisable at June 30, 2019     8,333     $ 20.00       0.25  
Warrants issued     -     $ -       -  
Warrants forfeited     (8,333 )   $ 20.00       -  
Warrants outstanding and exercisable at December 31, 2019     -     $ -       -  
Schedule of Stock Options Activity

Activity in stock options during the six months ended December 31, 2020 and related balances outstanding as of that date are reflected below:

 

    Number of Shares     Weighted Average Exercise Price    

Weighted Average Remaining Contract Term

(# years)

 
Outstanding at June 30, 2020     579,584     $ 11.00       7.55  
Granted     -     $ -       -  
Exercised     (10,750 )   $ 4.60       -  
Forfeited and cancelled     (7,463 )   $ 7.31       -  
Outstanding at December 31, 2020     561,371     $ 11.17       6.87  
Exercisable at December 31, 2020     493,224     $ 10.94       6.67  

 

Activity in stock options during the six months ended December 31, 2019 and related balances outstanding as of that date are reflected below:

 

    Number of Shares     Weighted Average Exercise Price    

Weighted Average Remaining

Contract Term

(# years)

 
Outstanding at June 30, 2019     580,171     $ 11.05       8.59  
Granted     -     $ -       -  
Exercised     (4,437 )   $ 4.69       -  
Forfeited and cancelled     (7,093 )   $ 12.32       -  
Outstanding at December 31, 2019     568,641     $ 11.08       8.07  
Exercisable at December 31, 2019     377,428     $ 10.47       7.71  
Schedule of Restricted Stock Units Activity

Activity in RSUs during the six months ended December 31, 2020 and related balances outstanding as of that date are reflected below:

 

    Number of Shares     Weighted Average Grant date Fair Value    

Weighted Average Remaining Contract Term

(# years)

 
Outstanding at June 30, 2020     -     $ -       -  
Granted     134,865     $ 8.88       -  
Forfeited and cancelled     (4,228 )   $ 8.88       -  
Outstanding at December 31, 2020     130,637     $ 8.88       3.15  
Schedule of Stock-Based Compensation Expenses

The following table summarizes stock-based compensation expense for employee and non-employee option grants and RSUs:

 

    Three Months Ended
December 31,
    Six Months Ended
December 31,
 
    2020     2019     2020     2019  
Research and development   $ 45,000     $ 54,000     $ 98,000     $ 108,000  
Selling and administrative     152,000       395,000       324,000       792,000  
Total stock-based compensation expense   $ 197,000     $ 449,000     $ 422,000     $ 900,000  
Schedule of Fair Value Assumptions of Stock Options

The Company uses the Black-Scholes valuation model to calculate the fair value of stock options. The fair value of stock options was measured at the grant date using the assumptions (annualized percentages) in the table below:

 

    Six Months Ended
December 31,
 
    2020     2019  
Expected volatility     0 %     111.4% -112.2 %
Risk free interest rate     0 %     2.43% - 2.45 %
Forfeiture rate     20 %     20 %
Dividend yield     0 %     0 %
Expected term (years)     0       5.61